[PDF] Top 20 Drug-eluting stent in diabetes

... that drug-eluting stents are preferable for treating diabetic patients with coronary ...omissions in the published studies make this statement ...of drug-eluting stents and consequently ... See full document

... angioplasty in drug­eluting stent restenosis: the PEPCAD-DES ...angioplasty in patients with restenosis after implanta­ tion of a drug-eluting stent (ISAR-DESIRE 3): a ... See full document

... 6. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. ... See full document

... 0,8 stent/ paciente e mais inibidores da glicoproteína IIb/IIIa (19,6% ...de stent (3,6% ...de stent na análise multivariada (RR 2,96, IC 95% 1,62-5,41; P < ... See full document

... during stent implantation is thought to be the main contributor to the development of restenosis ...and stent placement during PCI lead to the endothelial denudation and subintimal hemorrhage, which ... See full document

... everolimus-eluting stent (Abbott Vascular, Abbott Park, United States) for treating in-stent ...bare-metal stent restenosis were ...the drug-eluting balloon and for 12 ... See full document

... generation drug-eluting stents, while maintaining antiproliferative eficacy and increasing ...polymer-coated drug-eluting stents compared with identical platform metallic stents in ... See full document

... paclitaxel-derivate eluting polymer stents for 12 months; atherectomy specimens from these patients were collected and sent to pathological anatomy for electron microscopy ...the stent struts; there were ... See full document

... drug-eluting stent was approved by Chinese SDA (State Drug Administration) for commercial use in the beginning of 2005, the penetration of this drug-eluting stent ... See full document

... of drug- eluting stents (DES) are ...included in the study, 111 of whom were treated with DES and 109 with ...of diabetes (54% ...years, diabetes and lesions < 3.2 mm in ... See full document

... used in this study, this analysis may not generate the required or expected ...VI. In those studies, cardiac death was ...included in the ...study in the one year follow up category for the ... See full document

... (PrOmus eluting stent registry in Latin AmeRica): 1 Year Follow-up Results Background: Drug-eluting stents have been used since 2002 in different patient populations aiming to ... See full document

... 6. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. ... See full document

... of stent thrombosis has often catastrophic consequences, such as acute vessel occlusion, or even sudden ...death². Stent thrombosis is a topic that interests us, especially in the way we manage late ... See full document

... stent, of which 100 (35.2%) had multivessel coronary artery disease. This group was compared to 100 patients, of a group of 304 (38.9%) patients with multivessel coronary artery dis- ease treated with second ... See full document

... leiniger Ballonangioplastie für die Anwendung im femoro- poplitealen Arteriensegment für mittlere Läsionslängen zwi- schen 5 und 6 cm verglichen. Studienendpunkte waren die primäre Sicherheit (Tod, Amputation, ... See full document

... one drug-eluting stent in our medical ...of drug-eluting stents implanted was 189, of which 115 (61%) were sirolimus-eluting (CYPHER™) and 74 (39%) were ... See full document

... year in “real world” ...Biomatrix™ stent, a biolimus A9-eluting stent with biodegradable ...revascularization. Stent thrombosis occurred in only 1% (1 patient) at ...A9 ... See full document

... found in the patients’ risk of MACE between using the biodegradable polymer BES and the durable polymer SES, as well as other secondary outcomes, including all cause death, cardiac death, MI, clinically indicated ... See full document

... do stent Biomatrix™ (grupo BES) foram comparadas as de um stent de pri- meira geração eluidor de sirolimus com polímero du- rável (Cypher SELECT™, Cordis, Miami Lakes, FL, ...do stent eluidor de ... See full document